These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 20144195)

  • 21. Osteopontin deficiency protects mice from cholesterol gallstone formation by reducing expression of intestinal NPC1L1.
    Lin J; Shao WQ; Chen QZ; Zhu WW; Lu L; Jia HL; Chen JH
    Mol Med Rep; 2017 Aug; 16(2):1785-1792. PubMed ID: 28627641
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of ezetimibe on the prevention and dissolution of cholesterol gallstones.
    Wang HH; Portincasa P; Mendez-Sanchez N; Uribe M; Wang DQ
    Gastroenterology; 2008 Jun; 134(7):2101-10. PubMed ID: 18442485
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased activity of hepatic microsomal triglyceride transfer protein and bile acid synthesis in gallstone disease.
    Castro J; Amigo L; Miquel JF; Gälman C; Crovari F; Raddatz A; Zanlungo S; Jalil R; Rudling M; Nervi F
    Hepatology; 2007 May; 45(5):1261-6. PubMed ID: 17464999
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Osteopontin Deficiency Alters Biliary Homeostasis and Protects against Gallstone Formation.
    Lin J; Lu M; Shao WQ; Chen ZY; Zhu WW; Lu L; Jia HL; Cai D; Qin LX; Chen JH
    Sci Rep; 2016 Aug; 6():30215. PubMed ID: 27484115
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biliary lipid composition in patients with cholesterol and pigment gallstones and gallstone-free subjects: deoxycholic acid does not contribute to formation of cholesterol gallstones.
    Gustafsson U; Sahlin S; Einarsson C
    Eur J Clin Invest; 2000 Dec; 30(12):1099-106. PubMed ID: 11122325
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic variation in the cholesterol transporter NPC1L1, ischaemic vascular disease, and gallstone disease.
    Lauridsen BK; Stender S; Frikke-Schmidt R; Nordestgaard BG; Tybjærg-Hansen A
    Eur Heart J; 2015 Jul; 36(25):1601-8. PubMed ID: 25841872
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gallbladder bile supersaturated with cholesterol in gallstone patients preferentially develops from shortage of bile acids.
    Rudling M; Laskar A; Straniero S
    J Lipid Res; 2019 Mar; 60(3):498-505. PubMed ID: 30610083
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatic Niemann-Pick C1-like 1 regulates biliary cholesterol concentration and is a target of ezetimibe.
    Temel RE; Tang W; Ma Y; Rudel LL; Willingham MC; Ioannou YA; Davies JP; Nilsson LM; Yu L
    J Clin Invest; 2007 Jul; 117(7):1968-78. PubMed ID: 17571164
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention of cholesterol gallstone disease by schaftoside in lithogenic diet-induced C57BL/6 mouse model.
    Liu M; Liu C; Chen H; Huang X; Zeng X; Zhou J; Mi S
    Eur J Pharmacol; 2017 Nov; 815():1-9. PubMed ID: 28993159
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel function of Niemann-Pick C1-like 1 as a negative regulator of Niemann-Pick C2 protein.
    Yamanashi Y; Takada T; Shoda J; Suzuki H
    Hepatology; 2012 Mar; 55(3):953-64. PubMed ID: 22095670
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Progress of Niemann-Pick type C1 Like 1 on cholesterol metabolism].
    Yang JY; Hu YW; Zhang P; Zheng L; Wang Q
    Sheng Li Xue Bao; 2012 Dec; 64(6):721-8. PubMed ID: 23258338
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High level of deoxycholic acid in human bile does not promote cholesterol gallstone formation.
    Gustafsson U; Sahlin S; Einarsson C
    World J Gastroenterol; 2003 Jul; 9(7):1576-9. PubMed ID: 12854167
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The expression of hepatic carboxypeptidase E is decreased in patients with cholesterol gallstone.
    Dai SL; Zhou J; Yang KX; Yang SY
    Saudi J Gastroenterol; 2015; 21(4):226-31. PubMed ID: 26228366
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Claudin-3 regulates bile canalicular paracellular barrier and cholesterol gallstone core formation in mice.
    Tanaka H; Imasato M; Yamazaki Y; Matsumoto K; Kunimoto K; Delpierre J; Meyer K; Zerial M; Kitamura N; Watanabe M; Tamura A; Tsukita S
    J Hepatol; 2018 Dec; 69(6):1308-1316. PubMed ID: 30213590
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apical sodium bile acid transporter and ileal lipid binding protein in gallstone carriers.
    Bergheim I; Harsch S; Mueller O; Schimmel S; Fritz P; Stange EF
    J Lipid Res; 2006 Jan; 47(1):42-50. PubMed ID: 16237211
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overexpression of sterol carrier protein-2 mRNA in patients with cholesterol gallstones.
    Cui NQ; Zhang SK; Cui YF; Li DH; Chen C; Wu XZ
    Hepatobiliary Pancreat Dis Int; 2005 Feb; 4(1):117-20. PubMed ID: 15730934
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endurance exercise training reduces gallstone development in mice.
    Wilund KR; Feeney LA; Tomayko EJ; Chung HR; Kim K
    J Appl Physiol (1985); 2008 Mar; 104(3):761-5. PubMed ID: 18187606
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibiting intestinal NPC1L1 activity prevents diet-induced increase in biliary cholesterol in Golden Syrian hamsters.
    Valasek MA; Repa JJ; Quan G; Dietschy JM; Turley SD
    Am J Physiol Gastrointest Liver Physiol; 2008 Oct; 295(4):G813-22. PubMed ID: 18718997
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bile acid synthesis is increased in Chilean Hispanics with gallstones and in gallstone high-risk Mapuche Indians.
    Gälman C; Miquel JF; Pérez RM; Einarsson C; Ståhle L; Marshall G; Nervi F; Rudling M
    Gastroenterology; 2004 Mar; 126(3):741-8. PubMed ID: 14988828
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Triglycerides and gallstone formation.
    Smelt AH
    Clin Chim Acta; 2010 Nov; 411(21-22):1625-31. PubMed ID: 20699090
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.